Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 8, 2011	D		0001517022-11-000001.pdf 0001517022-11-000001.rtf 0001517022-11-000001.xls View HTML
April 21, 2011	D/A		0001517022-11-000002.pdf 0001517022-11-000002.rtf 0001517022-11-000002.xls View HTML
April 10, 2020	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-20-103794.pdf 0001193125-20-103794.rtf 0001193125-20-103794.xls View HTML
February 17, 2023	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-23-042106.pdf 0001193125-23-042106.rtf 0001193125-23-042106.xls View HTML
March 31, 2014	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-14-024204.pdf 0001104659-14-024204.rtf 0001104659-14-024204.xls View HTML
April 29, 2014	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001144204-14-025779.pdf 0001144204-14-025779.rtf 0001144204-14-025779.xls View HTML
January 6, 2015	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000790502-15-000007.pdf 0000790502-15-000007.rtf View HTML
February 9, 2015	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000897069-15-000107.pdf 0000897069-15-000107.rtf 0000897069-15-000107.xls View HTML
February 12, 2015	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001193125-15-046725.pdf 0001193125-15-046725.rtf 0001193125-15-046725.xls View HTML
January 28, 2016	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000215457-16-004460.pdf 0000215457-16-004460.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax